HE4 is the marker of choice in discriminating endometriosis from ovarian cancer in pelvic mass patients: Sub-analysis of a prospective multicentric study

Elena Ioana Braicu, U. Torsten, Rolf Richter, Carmen Beteta, J. Boneß-Zaloume, Desislava Dimitrova, Elisa Koch, F. Chen, Radoslav Chekerov, Kati Hasenbein, Jalid Sehouli
In: Gynecologic Oncology · 2018 · vol. 149 , pp. 242 · doi:10.1016/j.ygyno.2018.04.547 · W2811469944
article OA: closed CC0
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex
⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

Human epididymis protein 4 (HE4) effectively differentiates endometriosis from ovarian cancer in patients presenting with pelvic masses.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK